Immunology

Smart inhaler to help asthma sufferers breathe easier

With almost 30 million people under the age of 45 living with asthma in Europe, new 'smart inhalers' may provide better ways of treating the disease and help scientists understand what is driving this growing global epidemic.

Inflammatory disorders

New 'biologic' drug may help severe asthma

(HealthDay)—A "biologic" drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.

Medications

FDA approves cinqair for severe asthma

(HealthDay)—Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.

Inflammatory disorders

Cancer drug helps combat asthma in mice

In a mouse model of allergic asthma, dasatinib—an enzyme inhibitor approved for the treatment of chronic myelogenous leukemia—reduced inflammation, enhanced airway repair, and improved lung mechanics.

Diseases, Conditions, Syndromes

Glaxo plant with Legionnaires' bacteria is quiet for second day

All was quiet Wednesday at a GlaxoSmithKline pharmaceutical plant that was shut down after the drug maker discovered the bacteria that cause potentially fatal Legionnaires' disease in a cooling tower at the site.

Cardiology

Statins have benefits for asthma sufferers

Statins continue to show that their benefits extend beyond their original focus of lowering high cholesterol. With the increasing prevalence of asthma, scientists are studying the effects of statins in the lungs. In a new ...

page 3 from 8